CBU
VCYT icon

CIBC Bancorp USA’s Veracyte VCYT Stock Holding History

CIBC Bancorp USA’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Buy
+5,563
New +$233K ﹤0.01% 1494
2025
Q3 		$287K Buy
+8,356
New +$240K ﹤0.01% 1109

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIBC Bancorp USA's VCYT Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Veracyte (VCYT) in Q2 2026: 5,563 shares worth $327K. The stake represents ﹤0.01% of the portfolio and ranks #1494 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in VCYT as recently as Q3 2025.

CIBC Bancorp USA first reported a position in VCYT in Q3 2025 and has held it in 2 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • CIBC Bancorp USA held 5,563 shares of Veracyte worth $327K as of Q2 2026.
  • Veracyte was a new CIBC Bancorp USA position in Q2 2026.
  • Veracyte made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1494 holding.
  • CIBC Bancorp USA first reported a position in Veracyte in Q3 2025 and has held it in 2 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.